Cardiovascular effects of N-butylscopolammonium bromide and xylazine in horses.

This research explores the cardiovascular effects of N-butylscopolammonium bromide (NBB) and xylazine, two drugs frequently used to treat abdominal discomfort in horses. The study examined how these drugs, administered individually or together, impact heart rate, blood pressure, and other physiological aspects in horses.

Objective and Methods

• The main objective of this study was to measure the impacts of intravenous (i.v) administration of NBB, xylazine, and their combination on heart rate, blood pressure, and other commonly gauged physiological parameters in horses.
• In the experiment, six mature horses of mixed breeds were chosen. Each horse was administered with either 0.3mg/kg of NBB, 0.25 mg/kg of xylazine, or a blend of the two in a random cross-over design.
• The physiological responses, including heart rate, overall cardiac rhythm and indirect blood pressure were tracked at specific intervals before and 60 minutes after the drug administration.

Results

• The study found that heart rate and blood pressure were significantly increased immediately after the administration of NBB or a combination of NBB and xylazine.
• Administering the combination of NBB and xylazine resulted in considerably higher initial and peak blood pressure levels compared to applying NBB alone.
• Administering xylazine led to a decline in heart rate, an initial surge in blood pressure followed by a decrease.
• Administrations of NBB either alone or with xylazine led to sinus tachycardia, a condition characterized by an elevated heart rate. Xylazine administration also led to both first and second degree atrioventricular block, a type of heart rhythm disorder.

Conclusions

• The findings of the study suggest that NBB, either alone or in combination with xylazine, can significantly influence the cardiovascular system of horses. The drug effects should be carefully considered, particularly when administered to horses suffering from spasmodic colic or closely related symptoms.
• The study emphasizes the need for accurate assessment of a horse’s condition and prognosis before administering these medications to avoid potential adverse effects, as they could further complicate a horse’s health, especially if there’s an existing systemic cardiovascular compromise.